Funding

The Institute for Precision Health offers numerous funding opportunities to enhance your research and industrial collaborations via the UKRI MRC Impact Acceleration Accounts (IAA) award. Funding calls will be announced via the Institute and drugdiscovery@le.ac.uk mailbox at several points during the year. There may be further opportunity for small awards in between formal calls, so please email drugdiscovery@le.ac.uk to talk through your ideas.

Additionally, the Institute can provide funding to facilitate networking opportunities for grant development. Please contact Lynne Howells (lh28@le.ac.uk) for further information.

IPH PGR Studentship: Expression of interest from investigators

The Institute for Precision Health is pleased to announce that they will dedicate one IPH CLS PhD studentship for a collaborative project with the Leicester, Leicestershire and Rutland Integrated Care Board (LLR ICB) – this will be a health data science-based project based around project discussions at the ICB health data science and research conference on Tuesday 12 March 2024.

We are now calling for an expression of interest from investigators. PI must be from CLS (co-applicants from any college) and ICB must be involved as a collaborator.

Our priority areas are, cancer, cardiovascular and respiratory disorders, diabetes, ethnic health, health inequalities, infectious diseases and multiple long-term conditions.

To apply please provide:

• Name and department of PI, Cols and collaborators
• List 3 key project highlights
• Project overview (200 words)

Please send your applications to iph@le.ac.uk (cc lh28@le.ac.uk) by Friday 22 March 2024.

We would hope to advertise the projects after Easter and interview in June.

Postgraduate research

The Institute for Precision Health has an active postgraduate community. New studentships will be announced here, and we welcome enquiries about our PhD projects. 

Our students are undertaking world-leading research in the following areas:

Circulating RNA as a liquid biopsy for cancer detection and tissue-of-origin prediction

• Katie Anne Dixon, supervised by Professor Jacqui Shaw and Dr Ricky Joshi

Inequalities in precision medicine in under-served groups

• Monica Kundu, supervised by Professor Kamlesh Khunti and Drs Setor Kunutsor and Ash Routen

Proteomic investigation of markers of chronic inflammation in cardiovascular disease

• Ammar Akram, supervised by Dr Dennis Bernieh, Dr Pankaj Gupta and Professor Don Jones

Functional investigation of a potential novel drug target for progressive lung fibrosis

• Catherine McMullen, supervised by Dr Katy Roach and Professor Louise Wain

Developing a virtual asthma patient

• Mahesh Ola, supervised by Dr Himanshu Kaul and Professor Chris Brightling

Investigation of proteomic biomarkers of hypertension using microsampling-based mass spectrometry detection

• Elliott Gyedu, supervised by Dr Pankaj Gupta and Dr Dennis Bernieh

Radiomic and multiomic investigation of molecular pathways in concentric left ventricular myocardial remodelling in Type 2 Diabetes (T2DM)

• Nikita Bhakta, supervised by Professor Leong Ng and Dr Alastair Moss

Mechanisms of intrinsic resistance to bispecific antibodies in diffuse large B cell lymphoma (DLBCL)

• Joshua Bray, supervised by Dr Harriet Walter and Professor Martin Dyer

Understanding the effect of SGLT2i on muscle health in those with chronic disease

• Cian Sutcliffe, supervised by Professor Melanie Davies and Dr Luke Baker

Further research